Avanos Medical (NYSE:AVNS) announced today that it appointed David Pacitti as its new CEO, effective April 14, 2025.

Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.

Siemens Healthineers’ president of the Americas, David Pacitti, is leaving the imaging giant to become CEO of the devicemaker ...

Medical announced the appointment of David Pacitti as its new CEO, effective April 14. Pacitti joins Avanos with a distinguished ...

An update from Avanos Medical ( ($AVNS) ) is now available. On March 17, 2025, Avanos Medical announced the appointment of David Pacitti as its ...

Avanos Medical named David Pacitti as its next chief executive officer, effective April 14. The medical technology company will pay Pacitti a base salary around $1.1 million and he would be eligible ...

Highlights,Avanos Medical’s stock recently witnessed a shift in analyst ratings from "buy" to "hold".,Institutional investors ...

Investors need to pay close attention to Avanos (AVNS) stock based on the movements in the options market lately.

Highlights,Avanos Medical operates in the medical technology sector, specializing in advanced healthcare ...

Illinois Municipal Retirement Fund lifted its position in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 3.1% in ...

ALPHARETTA, Ga., Feb. 19, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and ...

Investors in Avanos Medical, Inc. AVNS need to pay close attention to the stock based on moves in the options market lately. That is because the April 17, 2025 $10.00 Call had some of the highest ...